For the Inventor, By the Inventor

Enter assignee name

Durham, NC, United States of America

Argos Therapeutics, Inc.

USPTO Granted Patents = 40

CIPO Patents = 12

EPO Patents = 16

Trademarks = 1

Forward Citations = 184

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Irina Tcherepanova (12 out of 13 patents)

Gerold Schuler (9 out of 18 patents)

Richard Alexander Grant (9 out of 12 patents)

4. Simon Jonathon Spence (7 out of 21 patents)

5. Timothy Doyle Peele (7 out of 8 patents)

6. Simon Harris (6 out of 16 patents)

7. William Samuel Hunter (6 out of 17 patents)

8. David Thomas Kneen (6 out of 6 patents)

9. Robert Alister Neil (6 out of 6 patents)

10. Ashraf Farid Abdelmoteleb (6 out of 7 patents)

11. Alexander Steinkasserer (5 out of 7 patents)

12. Matthias Lechmann (5 out of 6 patents)

13. Melissa Adams (5 out of 6 patents)

14. Tamara Tatroe Monesmith (4 out of 4 patents)

15. Detlef Dieckmann (4 out of 4 patents)

Core Competencies:

Dendritic Cell Compositions

Soluble CD83 Proteins

Humanized Antibodies

Cryoconserved Cells

HIV Detection

Immunomodulatory Polypeptides

Sample Processing

Pathogen Amplification

Transgenic Host Cells

Autoimmune Disease Treatment

Liquid Medicament Delivery

Closed Container Systems

40 patents: Sort by Forward Citations

1. 10184108 - Mature dendritic cell compositions and methods for culturing same (2019-01-22),

2. 10022731 - Centrifuge vessels with a center mound and an internal elongate tube suitable for live cell processing and associated systems and methods (2018-07-17),

3. 10006901 - [object Object] (2018-06-26),

4. 9970068 - Primers and probes for the amplification and detection of HIV GAG, REV and NEF polynucleotides (2018-05-15),

5. 9879053 - Strain-independent amplification of pathogens and vaccines thereto (2018-01-30),

6. 9732140 - Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases (2017-08-15),

7. 9638707 - Methods of processing samples (2017-05-02),

8. 9556455 - Mature dendritic cell compositions and methods for culturing same (2017-01-31),

9. 9527074 - Processing containers (2016-12-27),

10. 9523077 - Mature dendritic cell compositions and methods for culturing same (2016-12-20),

11. RE46152 - Dendritic cell compositions and methods (2016-09-19),

12. 9409178 - Processing containers (2016-08-09),

13. 9102726 - Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same (2015-08-11),

14. 9085807 - Strain-independent amplification of pathogens and vaccines thereto (2015-07-21),

15. 9040303 - Apparatus for measuring volume of a fluid (2015-05-26),

Argos Therapeutics, Inc. is a biopharmaceutical company specializing in the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases. With a focus on precision medicine, Argos Therapeutics aims to provide targeted therapies that harness the power of the patient’s own immune system to fight against diseases. Through their innovative Arcelis technology platform, they create personalized immunotherapies that are tailored to each patient. By combining immunotherapy with precision medicine, Argos Therapeutics strives to improve patient outcomes and revolutionize the field of personalized medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

40 Patents

#24 in Durham, NC

#190 in North Carolina

#8,342 in US

#16,561 in the World

Durham, NC, United States of America

Argos Therapeutics, Inc.

Forward Citations = 184

46 inventors:

Irina Tcherepanova (12 out of 13 patents)

Gerold Schuler (9 out of 18 patents)

Richard Alexander Grant (9 out of 12 patents)

4. Simon Jonathon Spence (7 out of 21 patents)

5. Timothy Doyle Peele (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…